As part of efforts to improve study design, the use of outcome measures in randomized controlled trials (RCTs) in traumatic brain injury (TBI) is receiving increasing attention. This review aimed to assess how clinical outcome assessments (COAs) have been used and reported in RCTs in adult TBI. Systematic literature searches were conducted to identify medium to large (n ≥ 100) acute and post-acute TBI trials published since 2000. Data were extracted independently by two reviewers using a set of structured templates. Items from the Consolidated Standards of Reporting Trials (CONSORT) 2010 Statement and CONSORT patient-reported outcomes (PROs) extension were used to evaluate reporting quality of COAs. Glasgow Outcome Scale/Extended (GOS/GOSE) data were extracted using a checklist developed specifically for the review. A total of 126 separate COAs were identified in 58 studies. The findings demonstrate heterogeneity in the use of TBI outcomes, limiting comparisons and meta-analyses of RCT findings. The GOS/GOSE was included in 39 studies, but implemented in a variety of ways, which may not be equivalent. Multi-dimensional outcomes were used in 30 studies, and these were relatively more common in rehabilitation settings. The use of PROs was limited, especially in acute study settings. Quality of reporting was variable, and key information concerning COAs was often omitted, making it difficult to know how precisely outcomes were assessed. Consistency across studies would be increased and future meta-analyses facilitated by (a) using common data elements (CDEs) recommendations for TBI outcomes and (b) following CONSORT guidelines when publishing RCTs.
Get full access to this article
View all access options for this article.
References
1.
WaltonM.K., PowersJ.H., HobartJ., PatrickD., MarquisP., VamvakasS., IsaacM., MolsenE., CanoS., and BurkeL.B. (2015). Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment—Emerging Good Practices for Outcomes Research Task Force. Value Health, 18, 741–752.
2.
SheehanJ., HirschfeldS., FosterE., GhitzaU., GoetzK., KarpinskiJ., LangL., MoserR.P., OdenkirchenJ., ReevesD., RubinsteinY., WernerE., and HuertaM. (2016). Improving the value of clinical research through the use of Common Data Elements. Clin. Trials, 13, 671–676.
3.
U.S. Food & Drug Administration (2017). Clinical Outcome Assessment Qualification Program. FDA, U.S. (ed). U.S. Food and Drug Administration: Silver Spring, MD.
4.
HicksR., GiacinoJ., Harrison-FelixC., ManleyG., ValadkaA., and WildeE.A. (2013). Progress in developing common data elements for traumatic brain injury research: version two—the end of the beginning. J. Neurotrauma, 30, 1852–1861.
5.
TosettiP., HicksR.R., TheriaultE., PhillipsA., KoroshetzW., and Draghia-AkliR. (2013). Toward an international initiative for traumatic brain injury research. J. Neurotrauma, 30, 1211–1222.
6.
WildeE.A., WhiteneckG.G., BognerJ., BushnikT., CifuD.X., DikmenS., FrenchL., GiacinoJ.T., HartT., MalecJ.F., MillisS.R., NovackT.A., ShererM., TulskyD.S., VanderploegR.D., and von SteinbuechelN. (2010). Recommendations for the use of common outcome measures in traumatic brain injury research. Arch. Phys. Med. Rehabil., 91, 1650–1660.e17.
7.
NelsonL.D., RansonJ., FergusonA.R., GiacinoJ., OkonwoD.O., ValadkaA.B., ManleyG.T., and McCreaM.A. (2017). Validating multi-dimensional outcome assessment using the TBI Common Data Elements: an analysis of the TRACK-TBI Pilot Study sample. J. Neurotrauma, 34 [Epub ahead of print].
Clinical Data Interchange Standards Consortium (2015). Therapeutic Area Data Standards User Guide for Traumatic Brain Injury Version 1.0 (Provisional). Available at: https://www.cdisc.org/standards/therapeutic-areas/traumatic-brain-injury. Last accessed November29, 2017.
10.
ManleyG.T., MacDonaldC.L., MarkowitzA., StephensonD., RobbinsA., GardnerR.C., WinklerE.A., BodienY., TaylorS., YueJ.K., KannanL., KumarA., McCreaM. and WangK.K.W. (2017). The Traumatic Brain Injury Endpoints Development (TED) Initiative: Progress on a Public-Private Regulatory Collaboration to Accelerate Diagnosis and Treatment of Traumatic Brain Injury. J Neurotrauma [Epub ahead of print].
11.
MaasA.I.R., Harrison-FelixC.L., MenonD., AdelsonP.D., BalkinT., BullockR., EngelD.C., GordonW., Langlois-OrmanJ., LewH.L., RobertsonC., TemkinN., ValadkaA., VerfaellieM., WainwrightM., WrightD.W., and SchwabK. (2011). Standardizing data collection in traumatic brain injury. J. Neurotrauma, 28, 177–187.
12.
AlaliA.S., VavrekD., BarberJ., DikmenS., NathensA.B., and TemkinN.R. (2015). Comparative study of outcome measures and analysis methods for traumatic brain injury trials. J. Neurotrauma, 32, 581–589.
13.
BraggeP., SynnotA., MaasA.I., MenonD.K., CooperD.J., RosenfeldJ.V., and GruenR.L. (2016). A state-of-the-science overview of randomized controlled trials evaluating acute management of moderate-to-severe traumatic brain injury. J. Neurotrauma, 33, 1461–1478.
14.
McMillanT., WilsonL., PonsfordJ., LevinH., TeasdaleG., and BondM. (2016). The Glasgow Outcome Scale—40 years of application and refinement. Nat. Rev. Neurol., 12, 477–485.
15.
NicholA.D., HigginsA.M., GabbeB.J., MurrayL.J., CooperD.J., and CameronP.A. (2011). Measuring functional and quality of life outcomes following major head injury: common scales and checklists. Injury, 42, 281–287.
16.
MenonD.K., and MaasA.I. (2015). Traumatic brain injury in 2014. Progress, failures and new approaches for TBI research. Nat. Rev. Neurol, 11, 71–72.
17.
WeirJ., SteyerbergE.W., ButcherI., LuJ., LingsmaH.F., McHughG.S., RoozenbeekB., MaasA.I.R., and MurrayG.D. (2012). Does the Extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale?. J. Neurotrauma, 29, 53–58.
18.
WilsonJ.T.L., PettigrewL.E.L., and TeasdaleG.M. (2000). Emotional and cognitive consequences of head injury in relation to the Glasgow outcome scale. J. Neurol. Neurosurg. Psychiatry, 69, 204–209.
19.
SchulzK.F., AltmanD.G., and MoherD. (2010). CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J. Clin. Epidemiol., 63, 834–840.
20.
LuJ., GaryK.W., CopolilloA., WardJ., NiemeierJ.P., and LapaneK.L. (2015). Randomized controlled trials in adult traumatic brain injury: a review of compliance to CONSORT statement. Arch. Phys. Med. Rehabil., 96, 702–714.
21.
Covidence (2017). Available at: https://www.covidence.org/. Last accessed November29, 2017.
22.
HigginsJ.P.T., AltmanD.G., GøtzscheP.C., JüniP., MoherD., OxmanA.D., SavovićJ., SchulzK.F., WeeksL., and SterneJ.A.C. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343:d5928.
23.
FreemantleN., CalvertM., WoodJ., EasthaughJ., and GriffinC. (2003). Composite outcomes in randomized trials: greater precision but with greater uncertainty?. JAMA, 289, 2554–2559.
24.
TemkinN.R., AndersonG.D., WinnH.R., EllenbogenR.G., BritzG.W., SchusterJ., LucasT., NewellD.W., MansfieldP.N., MachamerJ.E., BarberJ., and DikmenS.S. (2007). Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol. 6, 29–38.
25.
BagiellaE., NovackT.A., AnselB., Diaz-ArrastiaR., DikmenS., HartT., and TemkinN. (2010). Measuring outcome in traumatic brain injury treatment trials: recommendations from the traumatic brain injury clinical trials network. J. Head Trauma Rehabil., 25, 375–382.
26.
ZafonteR.D., BagiellaE., AnselB.M., NovackT.A., FriedewaldW.T., HesdorfferD.C., TimmonsS.D., JalloJ., EisenbergH., HartT., RickerJ.H., Diaz-ArrastiaR., MerchantR.E., TemkinN.R., MeltonS., and DikmenS.S. (2012). Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA, 308, 1993–2000.
27.
CalvertM., BlazebyJ., AltmanD.G., RevickiD.A., MoherD., and BrundageM.D. (2013). Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO Extension. JAMA, 309, 814–822.
28.
U.S. Food & Drug Administration (2009). Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Available at: https://www.fda.gov/RegulatoryInformation/Guidelines/ucm122046.htm Last accessed November29, 2017.
29.
WilsonJ.T.L., PettigrewL.E., and TeasdaleG.M. (1998). Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J. Neurotrauma, 15, 573–585.
30.
WilsonJ.T., SliekerF.J., LegrandV., MurrayG., StocchettiN., and MaasA.I. (2007). Observer variation in the assessment of outcome in traumatic brain injury: experience from a multicenter, international randomized clinical trial. Neurosurgery, 61, 123–128; discussion 128–129.
31.
DaceyR., DikmenS., TemkinN., McLeanA., ArmsdenG., and WinnH.R. (1991). Relative effects of brain and non-brain injuries on neuropsychological and psychosocial outcome. J. Trauma, 31, 217–222.
32.
LeongB.K., MazlanM., Abd RahimR.B., and GanesanD. (2013). Concomitant injuries and its influence on functional outcome after traumatic brain injury. Disabil. Rehabil., 35, 1546–1551.
33.
MaasA.I., MurrayG., HenneyH.3rd, KassemN., LegrandV., MangelusM., MuizelaarJ.P., StocchettiN., and KnollerN. (2006). Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 5, 38–45.
34.
WrightD.W., YeattsS.D., SilbergleitR., PaleschY.Y., HertzbergV.S., FrankelM., GoldsteinF.C., CaveneyA.F., Howlett-SmithH., BengelinkE.M., ManleyG.T., MerckL.H., JanisL.S., and BarsanW.G. (2014). Very early administration of progesterone for acute traumatic brain injury. N. Engl. J. Med., 371, 2457–2466.
35.
PettigrewL.E.L., WilsonJ.T.L., and TeasdaleG.M. (2003). Reliability of ratings on the Glasgow Outcome Scales from in-person and telephone structured interviews. J. Head Trauma Rehabil., 18, 252–258.
36.
WilsonJ.T.L., EdwardsP., FiddesH., StewartE., and TeasdaleG.M. (2002). Reliability of postal questionnaires for the Glasgow Outcome Scale. J. Neurotrauma, 19, 999–1005.
37.
AndrewsP.J., SinclairH.L., RodriguezA., HarrisB.A., BattisonC.G., RhodesJ.K., and MurrayG.D. (2015). Hypothermia for intracranial hypertension after traumatic brain injury. N. Engl. J. Med., 373, 2403–2412.
38.
GregsonB.A., RowanE.N., FrancisR., McNameeP., BoyersD., MitchellP., McCollE., ChambersI.R., UnterbergA., and MendelowA.D. (2015). Surgical Trial In Traumatic intraCerebral Haemorrhage (STITCH): a randomised controlled trial of Early Surgery compared with Initial Conservative Treatment. Health Technol. Assess., 19, 1–138.
39.
MendelowA.D., GregsonB.A., RowanE.N., FrancisR., McCollE., McNameeP., ChambersI.R., UnterbergA., BoyersD., and MitchellP.M. (2015). Early surgery versus initial conservative treatment in patients with traumatic intracerebral hemorrhage (STITCH[Trauma]): the first randomized trial. J. Neurotrauma, 32, 1312–1323.
EdwardsP., ArangoM., BalicaL., CottinghamR., El-SayedH., FarrellB., FernandesJ., GogichaisviliT., GoldenN., HartzenbergB., HusainM., UlloaM.I., JerbiZ., KhamisH., KomolafeE., LaloeV., LomasG., LudwigS., MazairacG., Munoz Sanchez MdeL., NasiL., OlldashiF., PlunkettP., RobertsI., SandercockP., ShakurH., SolerC., StockerR., SvobodaP., TrenklerS., VenkataramanaN.K., WasserbergJ., YatesD., and YutthakasemsuntS. (2005). Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet, 365, 1957–1959.
42.
RobertsI., YatesD., SandercockP., FarrellB., WasserbergJ., LomasG., CottinghamR., SvobodaP., BrayleyN., MazairacG., LaloeV., Munoz-SanchezA., ArangoM., HartzenbergB., KhamisH., YutthakasemsuntS., KomolafeE., OlldashiF., YadavY., Murillo-CabezasF., ShakurH., and EdwardsP. (2004). Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet, 364, 1321–1328.
43.
PrigatanoG.P. (2005). Impaired self-awareness after moderately severe to severe traumatic brain injury. Acta. Neurochir. Suppl., 93, 39–42.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
